Rvl Pharmaceuticals Plc
(OTC) OSMT
Rvl Pharmaceuticals Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$72.12M
Net Income (TTM)
$108.56M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
OSMT News
OSMT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rvl Pharmaceuticals Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
125
CEO
Brian A. Markison, CPA
Website
www.rvlpharma.comHeadquarters
Bridgewater, NJ 08807, US
OSMT Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-92%
Net Income Margin
-1%
Return on Equity
-81%
Return on Capital
-42%
Return on Assets
-40%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$103.40M
Operating Income
$1.75M
EBITDA
$48.86M
Operating Cash Flow
$17.59M
Capital Expenditure
$3.13M
Free Cash Flow
$14.46M
Cash & ST Invst.
$114.05M
Total Debt
$219.56M
Rvl Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.20M
-96.2%
Gross Profit
$1.05M
-97.4%
Gross Margin
47.77%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
302
N/A
Net Income
$26.35M
-205.2%
EBITDA
$17.80M
-963.9%
Quarterly Fundamentals
Net Cash
$23.30M
+75.9%
Accounts Receivable
$4.19M
-80.6%
Inventory
$824.00K
-96.2%
Long Term Debt
$701.00K
-99.7%
Short Term Debt
$30.96M
+1763.9%
Return on Assets
-40.22%
N/A
Return on Invested Capital
-41.99%
N/A
Free Cash Flow
$16.19M
-283.0%
Operating Cash Flow
$15.93M
-267.0%